A clinical research to study the effect of Sirunerunjil kudineer on KALLADAIPPU(urinary stones)

A prospective open labeled randomized clinical trial on "Kalladaippu" (Urolithiasis) with evaluation of trial drug "Siru Nerunjil kudineer"

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/08/009576

Enrollment

Registered

2017-08-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- KALLADAIPPU

Interventions

Intervention1: Siru nerunjil kudineer: 40ml bid orally for 30 days Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Patient with appropriate symptoms of renal colic pain nausea or vomiting haematuria oliguria dysuria excessive sweating Patient who are willing to sign consent form and undergo laboratory investigations

Exclusion criteria

Exclusion criteria: Pregnant and lactating women Diabetes mellitus Chronic appendicitis Pyelonephritis Cholecystitis Systemic hypertension Recurrent UTI Chronic kidney disease Bilateral obstructive uropathy

Design outcomes

Primary

Measure	Time frame
Therapeutic efficacy of Siru nerunjil kudineer on KALLADAIPPUTimepoint: 30 days	—

Secondary

Measure	Time frame
Evaluation of Siddha diagnostic parametersTimepoint: 30 days	—

Countries

India

Contacts

Public ContactG Subash chandran

Government Siddha Medical college and hospital

siddhadrgs21@gmail.com9443358271

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026